Media | Contact us

About us
Protecting our tomorrow
A firm focus on vaccines stands at the core of everything we do.
READ MORE
At a glance
Our Leadership Team
Governance
Business Ethics
Sustainability
What we do
From R&D to manufacturing
We are focused on the research, development and manufacturing of innovative life-saving vaccines
READ MORE
Products
Pipeline
INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more
Annual Report 2023
News
Events & Presentations
Financials
Stock information
Analysts
Annual General Meeting
Shareholder Portal
FAQ
Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE
Working With Us
Job Openings
Our Employees

Financial Reports

Download our annual and interim financial reports here.

Interim Results (Q3) as of 30 September 2024

November 15, 2024

English version (pdf)
Spreadsheet (xls)

Interim Results (Q2) as of 30 June 2024

August 22, 2024

English version (pdf)
Spreadsheet (xls)

Interim Results (Q1) as of 31 March 2024

May 8, 2024

English version (pdf)
Spreadsheet (xls)

Annual Report 2023

March 6, 2024

English version (pdf)
Spreadsheet (xls)

Interim Results (Q3) as of 30 September 2023

November 16, 2023

English version (pdf)
Spreadsheet (xls)

Interim Results (Q2) as of 30 June 2023

August 23, 2023

English version (pdf)
Spreadsheet (xls)

Interim Results (Q1) as of 31 March 2023

May 9, 2023

English version (pdf)
Spreadsheet (xls)

Annual Report 2022

March 2, 2023

English version (pdf)
Spreadsheet (xls)

Interim Results (Q3) as of 30 September 2022

November 9, 2022

English version (pdf)
Spreadsheet (xls)

Interim Results (Q2) as of 30 June 2022

August 24, 2022

English version (pdf)
Spreadsheet (xls)